COVID-19 Protection After Transplant Pilot Study
Conditions
- Kidney Transplant Recipients
Interventions
- BIOLOGICAL: BNT162b2 vaccine (Pfizer/BioNTech)
- BIOLOGICAL: mRNA-1273 vaccine (Moderna)
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators